Yuvidox 100 Tablet DT contains Cefpodoxime Proxetil 100mg, a third-generation oral cephalosporin antibiotic with broad-spectrum bactericidal activity. It is indicated for the treatment of various bacterial infections including respiratory tract infections (such as bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections, and otitis media. Cefpodoxime Proxetil exerts its effect by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The tablet is designed as a dispersible tablet (DT), facilitating ease of administration, especially in patients with difficulty swallowing. Yuvidox 100 is effective against both Gram-positive and Gram-negative organisms, including strains resistant to earlier generation cephalosporins. It is generally well-tolerated; however, common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, although rare, may occur and warrant immediate medical attention. Dosage should be individualized based on the severity of infection, renal function, and patient age. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Yuvidox 100 Tablet DT should be used under medical supervision, and the full prescribed course must be completed to prevent resistance development and ensure optimal therapeutic outcomes.